CZ286399B6 - Pharmaceutical preparation in the form of atomizing solution for reducing blood pressure - Google Patents
Pharmaceutical preparation in the form of atomizing solution for reducing blood pressure Download PDFInfo
- Publication number
- CZ286399B6 CZ286399B6 CZ19951811A CZ181195A CZ286399B6 CZ 286399 B6 CZ286399 B6 CZ 286399B6 CZ 19951811 A CZ19951811 A CZ 19951811A CZ 181195 A CZ181195 A CZ 181195A CZ 286399 B6 CZ286399 B6 CZ 286399B6
- Authority
- CZ
- Czechia
- Prior art keywords
- weight
- nifedipine
- solution
- ethyl oleate
- blood pressure
- Prior art date
Links
- 230000036772 blood pressure Effects 0.000 title claims abstract description 10
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract description 8
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229960001597 nifedipine Drugs 0.000 claims abstract description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims abstract description 25
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims abstract description 25
- 229940093471 ethyl oleate Drugs 0.000 claims abstract description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 5
- 230000001077 hypotensive effect Effects 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract description 2
- -1 Poly(ethylene glycol) Polymers 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 30
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 210000002200 mouth mucosa Anatomy 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 125000004925 dihydropyridyl group Chemical class N1(CC=CC=C1)* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- OJYGBLRPYBAHRT-IPQSZEQASA-N chloralose Chemical compound O1[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]21 OJYGBLRPYBAHRT-IPQSZEQASA-N 0.000 description 1
- 229950009941 chloralose Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008137 solubility enhancer Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9402193A HU214582B (hu) | 1994-07-26 | 1994-07-26 | Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására |
Publications (2)
Publication Number | Publication Date |
---|---|
CZ181195A3 CZ181195A3 (en) | 1996-02-14 |
CZ286399B6 true CZ286399B6 (en) | 2000-04-12 |
Family
ID=10985460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ19951811A CZ286399B6 (en) | 1994-07-26 | 1995-07-13 | Pharmaceutical preparation in the form of atomizing solution for reducing blood pressure |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPH08169829A (sh) |
AT (1) | AT402690B (sh) |
AU (1) | AU699386B2 (sh) |
BE (1) | BE1011413A4 (sh) |
CZ (1) | CZ286399B6 (sh) |
DE (1) | DE19527140A1 (sh) |
EE (1) | EE9500029A (sh) |
FR (1) | FR2722988B1 (sh) |
GB (1) | GB2291593B (sh) |
HR (1) | HRP950374A2 (sh) |
HU (1) | HU214582B (sh) |
IT (1) | IT1277348B1 (sh) |
LT (1) | LT4042B (sh) |
LV (1) | LV11026B (sh) |
PL (1) | PL181069B1 (sh) |
SK (1) | SK280463B6 (sh) |
UA (1) | UA39880C2 (sh) |
YU (1) | YU50795A (sh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
EP1029536B1 (en) * | 1997-10-01 | 2007-11-28 | Novadel Pharma Inc. | Buccal non-polar spray |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
JP5577021B2 (ja) * | 2005-02-17 | 2014-08-20 | アボット・ラボラトリーズ | 動物における障害を治療および予防するための薬剤組成物の経粘膜投与 |
DE102006027794A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Antihypertonie-Kombinationswafer |
FR2906140B1 (fr) * | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
EP0175671A1 (de) | 1984-08-23 | 1986-03-26 | Kuhlemann & Co. | Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung |
DE3544692A1 (de) * | 1985-12-18 | 1987-06-19 | Bayer Ag | Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung |
US4869899A (en) * | 1986-03-10 | 1989-09-26 | Walter Burghart | Pharmaceutical preparation and process for producing the same |
EP0267617B1 (en) * | 1986-11-14 | 1992-06-24 | Theratech, Inc. | Penetration enhancement with binary system of cell envelope disordering compounds and lower alcohols |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
JPS63170316A (ja) * | 1986-12-30 | 1988-07-14 | Fujimoto Seiyaku Kk | ニフエジピン経皮吸収外用製剤 |
DE3714402A1 (de) * | 1987-04-30 | 1988-11-10 | Kali Chemie Pharma Gmbh | Arzneimittelformulierung |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
AT391269B (de) * | 1988-12-30 | 1990-09-10 | Burghart Kurt | Pharmazeutische zubereitung |
US5298258A (en) * | 1989-12-28 | 1994-03-29 | Nitto Denko Corporation | Acrylic oily gel bioadhesive material and acrylic oily gel preparation |
HU205249B (en) * | 1990-11-09 | 1992-04-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing suspensive aerosole composition |
-
1994
- 1994-07-26 HU HU9402193A patent/HU214582B/hu unknown
-
1995
- 1995-06-27 AU AU23269/95A patent/AU699386B2/en not_active Ceased
- 1995-06-30 HR HRP9402193A patent/HRP950374A2/hr not_active Application Discontinuation
- 1995-07-13 CZ CZ19951811A patent/CZ286399B6/cs not_active IP Right Cessation
- 1995-07-17 AT AT0121495A patent/AT402690B/de not_active IP Right Cessation
- 1995-07-17 FR FR9508598A patent/FR2722988B1/fr not_active Expired - Fee Related
- 1995-07-20 SK SK922-95A patent/SK280463B6/sk unknown
- 1995-07-20 LT LT95-084A patent/LT4042B/lt not_active IP Right Cessation
- 1995-07-21 JP JP7185275A patent/JPH08169829A/ja active Pending
- 1995-07-24 BE BE9500646A patent/BE1011413A4/fr not_active IP Right Cessation
- 1995-07-24 PL PL95309757A patent/PL181069B1/pl not_active IP Right Cessation
- 1995-07-25 DE DE19527140A patent/DE19527140A1/de not_active Withdrawn
- 1995-07-25 EE EE9500029A patent/EE9500029A/xx unknown
- 1995-07-25 UA UA95073513A patent/UA39880C2/uk unknown
- 1995-07-25 LV LVP-95-225A patent/LV11026B/en unknown
- 1995-07-25 GB GB9515205A patent/GB2291593B/en not_active Expired - Fee Related
- 1995-07-26 IT IT95MI001621A patent/IT1277348B1/it active IP Right Grant
- 1995-07-26 YU YU50795A patent/YU50795A/sh unknown
Also Published As
Publication number | Publication date |
---|---|
LT4042B (en) | 1996-09-25 |
GB9515205D0 (en) | 1995-09-20 |
GB2291593A (en) | 1996-01-31 |
LV11026A (lv) | 1996-02-20 |
ATA121495A (de) | 1996-12-15 |
ITMI951621A0 (it) | 1995-07-26 |
SK280463B6 (sk) | 2000-02-14 |
HRP950374A2 (en) | 1997-10-31 |
CZ181195A3 (en) | 1996-02-14 |
FR2722988A1 (fr) | 1996-02-02 |
LV11026B (en) | 1996-04-20 |
UA39880C2 (uk) | 2001-07-16 |
PL309757A1 (en) | 1996-02-05 |
DE19527140A1 (de) | 1996-02-01 |
IT1277348B1 (it) | 1997-11-10 |
EE9500029A (et) | 1996-02-15 |
JPH08169829A (ja) | 1996-07-02 |
AT402690B (de) | 1997-07-25 |
BE1011413A4 (fr) | 1999-09-07 |
AU699386B2 (en) | 1998-12-03 |
SK92295A3 (en) | 1996-05-08 |
HUT75457A (en) | 1997-05-28 |
ITMI951621A1 (it) | 1997-01-26 |
GB2291593B (en) | 1998-03-11 |
PL181069B1 (pl) | 2001-05-31 |
HU214582B (hu) | 1998-04-28 |
FR2722988B1 (fr) | 1999-10-08 |
YU50795A (sh) | 1998-05-15 |
AU2326995A (en) | 1996-02-08 |
LT95084A (en) | 1996-06-25 |
HU9402193D0 (en) | 1994-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3702965B2 (ja) | 哺乳動物、特に犬猫のノミを防除するための殺虫剤の組合せ | |
US6001384A (en) | Method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same | |
DE60132108T2 (de) | Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion | |
KR100740393B1 (ko) | 미녹시딜 함유 제제 | |
EP0673245B1 (fr) | Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation | |
CH630260A5 (fr) | Compositions antibiotiques a base d'une tetracycline. | |
SK12993A3 (en) | Pharmaceutical composition of florfenicol | |
SK286371B6 (sk) | Farmaceutický prostriedok | |
EA002879B1 (ru) | Микрогранулы омепразола, защищенные от желудочного сока, способ их получения и фармацевтические препараты | |
US5538989A (en) | Fenbendazole formulations | |
CZ286399B6 (en) | Pharmaceutical preparation in the form of atomizing solution for reducing blood pressure | |
CZ302737B6 (cs) | Suspenze obsahující oxkarbazepin | |
SK15922003A3 (sk) | Farmaceutický prostriedok s maskovanou chuťou a spôsob jeho prípravy | |
KR20010031128A (ko) | 탈모 방지 및 치료용 화장품 제재 | |
HU201242B (en) | Process for production of medical compositions containing niphedipin | |
DE4124409B4 (de) | Pharmazeutische Zubereitungen | |
CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
BE1006829A3 (fr) | Compositions pharmaceutiques solides. | |
EP0433909A2 (en) | Formulation | |
WO1997036486A1 (fr) | Solution cutanee pour depot direct a usage anti-parasitaire chez les bovins et ovins | |
FI96742B (fi) | Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi | |
EP0326103B1 (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
AU2002100152B4 (en) | Parasiticide composition | |
CS257777B2 (en) | Method of syringe oxytetracycline solutions preparation | |
CZ282830B6 (cs) | Léčivá mast bez dráždivého účinku na kůži a způsob její přípravy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF00 | In force as of 2000-06-30 in czech republic | ||
MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20020713 |